Edition:
United States

PuriCore PLC (PURI.L)

PURI.L on London Stock Exchange

30.50GBp
29 Sep 2016
Change (% chg)

0.00p (+0.00%)
Prev Close
30.50p
Open
30.50p
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,374
52-wk High
30.95p
52-wk Low
16.90p

PURI.L

Chart for PURI.L

About

PuriCore Plc is a biopharmaceutical company engaged in leveraging its immunomodulatory technology to protect and improve the health of adults and children. The Company is also engaged in development of small molecule therapies in inflammatory diseases with application in dermatology, ophthalmology and rare diseases, and also for... (more)
No analyst recommendations are available for PURI.L.

Overall

Beta: 0.57
Market Cap(Mil.): £15.35
Shares Outstanding(Mil.): 50.14
Dividend: --
Yield (%): --

Financials

  PURI.L Industry Sector
P/E (TTM): -- 43.83 36.83
EPS (TTM): -0.09 -- --
ROI: -29.07 -0.29 13.93
ROE: -29.07 -2.99 14.84

BRIEF-Puricore wins two U.S. patents for development of skin disease drugs

* Puricore receives two U.S. patents covering drug development in inflammatory skin diseases Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

Aug 17 2016

Earnings vs. Estimates